25-hydroxyvitamin D levels and the risk of mortality in the general population

被引:942
作者
Melamed, Michal L. [1 ,2 ]
Michos, Erin D. [3 ]
Post, Wendy [3 ,5 ]
Astor, Brad [4 ,5 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Div Nephrol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
D O I
10.1001/archinte.168.15.1629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients undergoing dialysis, therapy with calcitriol or paricalcitol or other vitamin D agents is associated with reduced mortality. Observational data suggests that low 25-hydroxyvitamin D levels (25[OH]D) are associated with diabetes mellitus, hypertension, and cancers. However, whether low serum 25(OH)D levels are associated with mortality in the general population is unknown. Methods: We tested the association of low 25(OH)D levels with all-cause, cancer, and cardiovascular disease (CVD) mortality in 13 331 nationally representative adults 20 years or older from the Third National Health and Nutrition Examination Survey (NHANES III) linked mortality files. Participant vitamin D levels were collected from 1988 through 1994, and individuals were passively followed for mortality through 2000. Results: In cross-sectional multivariate analyses, increasing age, female sex, nonwhite race/ethnicity, diabetes, current smoking, and higher body mass index were all independently associated with higher odds of 25 (OH)D deficiency (lowest quartile of 25(OH)D level, <17.8 ng/mL [to convert to nanomoles per liter, multiply by 2.496]), while greater physical activity, vitamin D supplementation, and nonwinter season were inversely associated. During a median 8.7 years of follow-up, there were 1806 deaths, including 777 from CVD. In multivariate models (adjusted for baseline demographics, season, and traditional and novel CVD risk factors), compared with the highest quartile, being in the lowest quartile (25 [OH] D levels <17.8 ng/mL) was associated with a 26% increased rate of all-cause mortality (mortality rate ratio, 1.26; 95% CI, 1.08-1.46) and a population attributable risk of 3.1%. The adjusted models of CVD and cancer mortality revealed a higher risk, which was not statistically significant. Conclusion: The lowest quartile of 25(OH)D level (<17.8 ng/mL) is independently associated with all-cause mortality in the general population.
引用
收藏
页码:1629 / 1637
页数:9
相关论文
共 47 条
[1]  
[Anonymous], 1991, INT CLASS DIS 9 REV
[2]   Body fat content and 25-hydroxyvitamin D levels in healthy women [J].
Arunabh, S ;
Pollack, S ;
Yeh, J ;
Aloia, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :157-161
[3]   Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials [J].
Autier, Philippe ;
Gandini, Sara .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1730-1737
[4]   Antiproliferative role of vitamin D and its analogs - a brief overview [J].
Banerjee, P ;
Chatterjee, M .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 253 (1-2) :247-254
[5]  
Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P809
[6]  
Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P1253
[7]   Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [J].
Bischoff-Ferrari, Heike A. ;
Giovannucci, Edward ;
Willett, Walter C. ;
Dietrich, Thomas ;
Dawson-Hughes, Bess .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) :18-28
[8]   Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis [J].
Bjelakovic, Goran ;
Nikolova, Dimitrinka ;
Gluud, Lise Lotte ;
Simonetti, Rosa G. ;
Gluud, Christian .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08) :842-857
[9]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[10]   25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey [J].
Chonchol, M. ;
Scragg, R. .
KIDNEY INTERNATIONAL, 2007, 71 (02) :134-139